Research indicates that myrcophenostatin protects against COPD-associated inflammation and emphysema by regulating genes for pro-inflammatory mediators like TNF-α, IL-1β, G-CSF, and KC. The gene discussed is CSF3; the disease is pulmonary emphysema.